Author name: DrugPatentWatch – Make Better Decisions

REMODULIN (treprostinil) United therap Patent: 10,076,505 Expiration: Dec 16, 2024 See More … For more information on how DrugPatentWatch can […]

REMODULIN (treprostinil) United therap Patent: 10,076,505 Expiration: Dec 16, 2024 See More … For more information on how DrugPatentWatch can […]

SUMAVEL DOSEPRO (sumatriptan succinate) Endo operations Patent: 8,287,489 Expiration: Dec 6, 2024 See More … For more information on how […]

ACULAR LS (ketorolac tromethamine) Abbvie Patent: 8,377,982 Expiration: Nov 28, 2024 See More … For more information on how DrugPatentWatch […]

EVZIO (naloxone hydrochloride) Kaleo inc Patent: 9,737,669 Expiration: Nov 23, 2024 See More … For more information on how DrugPatentWatch […]

PONVORY (ponesimod) Vanda pharms inc Patent: 9,000,018 Expiration: Nov 16, 2024 See More … For more information on how DrugPatentWatch […]

PONVORY (ponesimod) Vanda pharms inc Patent: 9,000,018 Expiration: Nov 16, 2024 See More … For more information on how DrugPatentWatch […]

DEFENCATH (heparin sodium; taurolidine) Cormedix Patent: 9,339,036 Expiration: Nov 2, 2024 See More … For more information on how DrugPatentWatch […]

BYDUREON (exenatide synthetic) Astrazeneca ab Patent: 9,238,076 Expiration: Oct 15, 2024 See More … For more information on how DrugPatentWatch […]

NUCYNTA ER (tapentadol hydrochloride) Collegium pharm inc Patent: 8,114,383 Expiration: Oct 10, 2024 See More … For more information on […]